Editorial expression of concern: Antiproliferative effect of growth hormone-releasing hormone (GHRH) antagonist on ovarian cancer cells through the EGFR-Akt pathway(Reprod Biol Endocrinol, (2010), 8, 54, 10.1186/1477-7827-8-54)

Publication: Reproductive Biology and Endocrinology
UBC Author(s): Peter C Leung (Obstetrics & Gynaecology / Faculty of Medicine)
Volume: 24
Publication Date: December 2026